Related Experiment Video
Updated: Jun 22, 2026

Cost-Efficient Transcriptomic-Based Drug Screening
Published on: February 23, 2024
Bayesian modeling in virtual high throughput screening
1Department of Molecular Modeling, Pharmacopeia Drug Discovery Inc., P.O. Box 5350 Princeton, NJ 08543-5350, USA. aklon@locuspharma.com
Abstract:
Naïve Bayesian classifiers are a relatively recent addition to the arsenal of tools available to computational chemists. These classifiers fall into a class of algorithms referred to broadly as machine learning algorithms. Bayesian classifiers may be used in conjunction with classical modeling techniques to assist in the rapid virtual screening of large compound libraries in a systematic manner with a minimum of human intervention. This approach allows computational scientists to concentrate their efforts on their core strengths of model building. Bayesian classifiers have an added advantage of being able to handle a variety of numerical or binary data such as physicochemical properties or molecular fingerprints, making the addition of new parameters to existing models a relatively straightforward process. As a result, during a drug discovery project these classifiers can better evolve with the needs of the projects from general models in the lead finding stages to increasingly precise models in the lead optimization stages that are of particular interest to a specific medicinal chemistry team. Although other machine learning algorithms abound, Bayesian classifiers have been shown to compare favorably under most working conditions and have been shown to be tolerant of noisy experimental data.
Related Concept Videos
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Genetic Screens
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This relationship...
Pharmacokinetic Models: Overview
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal assumptions,...

